Samuel Moskowitz, MD
Sam Moskowitz received his AB summa cum laude from Princeton University in 1986 and his MD magna cum laude in 1994 from Harvard Medical School. His primary clinical interest is pediatric pulmonology, and his primary research focus is the investigation of chronic airway infection by Pseudomonas aeruginosa in cystic fibrosis, a lethal genetic disorder. Dr. Moskowitz previously did research in human molecular genetics, focusing on the lysosomal storage disorders alpha-L-iduronidase deficiency (Hurler and Scheie syndromes) and beta-hexosaminidase deficiency (Tay-Sachs disease).
Dr. Moskowitz directs the Cystic Fibrosis Center, the Pediatric CF Clinical Program, and the CF Basic Science Program at Massachusetts General Hospital. He is Associate Chief of the Pediatric Pulmonary Unit at MassGeneral Hospital for Children and Assistant Professor of Pediatrics at Harvard Medical School. He has previously held clinical and academic positions at Seattle Children's Hospital, University of Washington Medical Center, and the University of Washington School of Medicine.
In addition to his research on lung infections in cystic fibrosis, Dr. Moskowitz also provides care for individuals with cystic fibrosis and other chronic lung disorders such as asthma, bronchopulmonary dysplasia, congenital airway anomalies, diaphragmatic hernia, immunodeficiency, and primary ciliary dyskinesia, in both inpatient and outpatient settings.
Dr. Moskowitz and other members of the Division of Pediatric Pulmonary Medicine at MassGeneral Hospital for Children pursue an interdisciplinary team-based approach to caring for children and adolescents with lung disorders. This approach takes into account not only the individual’s clinical situation, but also the family and social context that shapes the patient’s experience of lung disease.